nodes	percent_of_prediction	percent_of_DWPC	metapath
Piroxicam—PTGS2—Nicotinate metabolism—NMNAT1—age related macular degeneration	0.153	0.153	CbGpPWpGaD
Piroxicam—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0462	0.0462	CbGpPWpGaD
Piroxicam—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0352	0.0352	CbGpPWpGaD
Piroxicam—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.0336	0.0336	CbGpPWpGaD
Piroxicam—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0294	0.0294	CbGpPWpGaD
Piroxicam—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT1—age related macular degeneration	0.0293	0.0293	CbGpPWpGaD
Piroxicam—PTGS1—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0235	0.0235	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.0221	0.0221	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.0211	0.0211	CbGpPWpGaD
Piroxicam—SLC22A11—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.021	0.021	CbGpPWpGaD
Piroxicam—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.02	0.02	CbGpPWpGaD
Piroxicam—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.0193	0.0193	CbGpPWpGaD
Piroxicam—PTGS2—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0186	0.0186	CbGpPWpGaD
Piroxicam—PTGS2—S1P1 pathway—KDR—age related macular degeneration	0.0179	0.0179	CbGpPWpGaD
Piroxicam—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.0178	0.0178	CbGpPWpGaD
Piroxicam—SLC22A8—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.016	0.016	CbGpPWpGaD
Piroxicam—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0134	0.0134	CbGpPWpGaD
Piroxicam—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.0133	0.0133	CbGpPWpGaD
Piroxicam—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.0128	0.0128	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.012	0.012	CbGpPWpGaD
Piroxicam—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0107	0.0107	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0107	0.0107	CbGpPWpGaD
Piroxicam—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.0102	0.0102	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.0102	0.0102	CbGpPWpGaD
Piroxicam—PTGS2—S1P1 pathway—VEGFA—age related macular degeneration	0.00984	0.00984	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00981	0.00981	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00913	0.00913	CbGpPWpGaD
Piroxicam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.00903	0.00903	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00813	0.00813	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00813	0.00813	CbGpPWpGaD
Piroxicam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.00797	0.00797	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00762	0.00762	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00717	0.00717	CbGpPWpGaD
Piroxicam—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00694	0.00694	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00688	0.00688	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00684	0.00684	CbGpPWpGaD
Piroxicam—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.0068	0.0068	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00679	0.00679	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00679	0.00679	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00669	0.00669	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00598	0.00598	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00569	0.00569	CbGpPWpGaD
Piroxicam—PTGS1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00566	0.00566	CbGpPWpGaD
Piroxicam—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00563	0.00563	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00557	0.00557	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00546	0.00546	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—F13B—age related macular degeneration	0.00538	0.00538	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00537	0.00537	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—CD36—age related macular degeneration	0.00529	0.00529	CbGpPWpGaD
Piroxicam—SLC22A11—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00527	0.00527	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00506	0.00506	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00504	0.00504	CbGpPWpGaD
Piroxicam—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00485	0.00485	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00463	0.00463	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0046	0.0046	CbGpPWpGaD
Piroxicam—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00458	0.00458	CbGpPWpGaD
Piroxicam—PTGS2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00449	0.00449	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00442	0.00442	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—RAD51B—age related macular degeneration	0.00439	0.00439	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—TLR4—age related macular degeneration	0.00414	0.00414	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00408	0.00408	CbGpPWpGaD
Piroxicam—SLC22A8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00402	0.00402	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00396	0.00396	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00377	0.00377	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.00365	0.00365	CbGpPWpGaD
Piroxicam—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00364	0.00364	CbGpPWpGaD
Piroxicam—PTGS2—Spinal Cord Injury—CCL2—age related macular degeneration	0.00355	0.00355	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00353	0.00353	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00353	0.00353	CbGpPWpGaD
Piroxicam—PTGS2—Disease—NMNAT1—age related macular degeneration	0.00346	0.00346	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RDH8—age related macular degeneration	0.00346	0.00346	CbGpPWpGaD
Piroxicam—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00335	0.00335	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.00319	0.00319	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RPE65—age related macular degeneration	0.00303	0.00303	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00296	0.00296	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—NMNAT1—age related macular degeneration	0.0029	0.0029	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00285	0.00285	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.00257	0.00257	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—ELOVL4—age related macular degeneration	0.00253	0.00253	CbGpPWpGaD
Piroxicam—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.00252	0.00252	CbGpPWpGaD
Piroxicam—PTGS2—Disease—ABCA4—age related macular degeneration	0.00244	0.00244	CbGpPWpGaD
Piroxicam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.0024	0.0024	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00235	0.00235	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00235	0.00235	CbGpPWpGaD
Piroxicam—ALB—Metabolism—NMNAT1—age related macular degeneration	0.00235	0.00235	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Piroxicam—PTGS2—Disease—RHO—age related macular degeneration	0.00212	0.00212	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.00206	0.00206	CbGpPWpGaD
Piroxicam—ALB—Metabolism—ELOVL4—age related macular degeneration	0.00205	0.00205	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—SLC16A8—age related macular degeneration	0.00204	0.00204	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00192	0.00192	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00191	0.00191	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.0019	0.0019	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Piroxicam—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Piroxicam—ALB—Metabolism—SLC16A8—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Piroxicam—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.0015	0.0015	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Piroxicam—PTGS2—Disease—CST3—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—LIPC—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CETP—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—CD36—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Piroxicam—PTGS2—Disease—TGFBR1—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Piroxicam—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—LIPC—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CETP—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000977	0.000977	CbGpPWpGaD
Piroxicam—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000972	0.000972	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000902	0.000902	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000851	0.000851	CbGpPWpGaD
Piroxicam—ALB—Metabolism—LIPC—age related macular degeneration	0.000846	0.000846	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000821	0.000821	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CETP—age related macular degeneration	0.000816	0.000816	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—CD36—age related macular degeneration	0.000764	0.000764	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000693	0.000693	CbGpPWpGaD
Piroxicam—PTGS1—Metabolism—APOE—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000668	0.000668	CbGpPWpGaD
Piroxicam—PTGS2—Disease—APOE—age related macular degeneration	0.000639	0.000639	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—CD36—age related macular degeneration	0.000606	0.000606	CbGpPWpGaD
Piroxicam—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000576	0.000576	CbGpPWpGaD
Piroxicam—PTGS2—Metabolism—APOE—age related macular degeneration	0.000535	0.000535	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000493	0.000493	CbGpPWpGaD
Piroxicam—ALB—Metabolism—CD36—age related macular degeneration	0.000491	0.000491	CbGpPWpGaD
Piroxicam—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000435	0.000435	CbGpPWpGaD
Piroxicam—ALB—Metabolism—APOE—age related macular degeneration	0.000433	0.000433	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000402	0.000402	CbGpPWpGaD
Piroxicam—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000354	0.000354	CbGpPWpGaD
